INS and metabolic disease: Early identification of pathogenic factors in the development of obesity related metabolic diseases such as insulin resistance, chronic inflammation, insulin secretion defect or adipose tissue dysfunction could result in personalized prevention or treatment strategies for individuals at high risk.